Rothwell Investment Advisors, LLC’s ProKidney PROK Stock Holding History

Rothwell Investment Advisors, LLC’s Portfolio PROK Stock Details PROK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$2	Buy	+1	New	+$2	﹤0.01%	1137

Other funds holding PROK

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return

Brown University Providence, Rhode Island $147M AUM 5.01% 1-Year Est. Return

Simplify Asset Management Las Vegas, Nevada $6.11B AUM 3.71% 1-Year Est. Return

Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Abel Hall LLC Baton Rouge, Louisiana $556M AUM 43.18% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $64.1B AUM 28.9% 1-Year Est. Return

Rothwell Investment Advisors, LLC's PROK Position: Q3 2026 in Review

Rothwell Investment Advisors, LLC opened a new position in ProKidney (PROK) in Q3 2026: 1 share worth $2. The stake represents ﹤0.01% of the portfolio and ranks #1137 among its holdings.

32 funds tracked by Wall St. Rank hold PROK as of Q3 2026.

Rothwell Investment Advisors, LLC held 1 share of ProKidney worth $2 as of Q3 2026.
ProKidney was a new Rothwell Investment Advisors, LLC position in Q3 2026.
ProKidney made up ﹤0.01% of Rothwell Investment Advisors, LLC's portfolio in Q3 2026, its #1137 holding.
32 funds tracked by Wall St. Rank held ProKidney as of Q3 2026.

Based on Rothwell Investment Advisors, LLC's 13F filing for Q3 2026, filed 6 Nov 2026.